Litcius/Paper detail

Another string to your bow: machine learning prediction of the pharmacokinetic properties of small molecules

Davide Bassani, Neil Parrott, Nenad Manevski, Jitao David Zhang

2024Expert Opinion on Drug Discovery32 citationsDOIOpen Access PDF

Abstract

INTRODUCTION: Prediction of pharmacokinetic (PK) properties is crucial for drug discovery and development. Machine-learning (ML) models, which use statistical pattern recognition to learn correlations between input features (such as chemical structures) and target variables (such as PK parameters), are being increasingly used for this purpose. To embed ML models for PK prediction into workflows and to guide future development, a solid understanding of their applicability, advantages, limitations, and synergies with other approaches is necessary. AREAS COVERED: extrapolation (IVIVE) and physiologically based pharmacokinetic (PBPK) models. The authors illustrate scenarios in which the three approaches are used and emphasize how they enhance and complement each other. In particular, they highlight achievements, the state of the art and potentials of applying machine learning for PK prediction through a comphrehensive literature review. EXPERT OPINION: ML models, when carefully crafted, regularly updated, and appropriately used, empower users to prioritize molecules with favorable PK properties. Informed practitioners can leverage these models to improve the efficiency of drug discovery and development process.

Topics & Concepts

Small moleculeString (physics)Computer scienceArtificial intelligenceDrug discoveryMachine learningPhysicsNanotechnologyChemistryMaterials scienceTheoretical physicsBiochemistryComputational Drug Discovery MethodsMachine Learning in Materials SciencePharmacogenetics and Drug Metabolism